EUIPO trademark

RIBOLYSINS

RegisteredEUIPOWord markClass 1Class 5Class 40Class 42+1

"RIBOLYSINS" is a word mark owned by BioNTech SE, filed at the EUIPO on September 25, 2025. It is registered and covers classes 1, 5, 40, 42 and 44.

View BioNTech SE portfolioGet this data via the API
Official EUIPO record
RIBOLYSINS
Word mark as filed with the EUIPO
Status
Registered
Since February 16, 2026
Filed
September 25, 2025
Registered
February 13, 2026
Expires
September 25, 2035
Application no.
019252243
Registration no.
019252243
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
5 classes
Ownership

Who owns RIBOLYSINS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

BioNTech SE

188 trademarks in the portfolioView company

Representative

df-mp Patentanwälte Rechtsanwälte PartG mbB

df-mp Patentanwälte Rechtsanwälte PartG mbB

Goods and services

What the mark covers

The products and services RIBOLYSINS is filed for, grouped by Nice class.

  • Chemical agents for laboratory use, in particular nucleic acids, peptides and proteins; chemical agents for the production of anticancer drugs and vaccines, in particular nucleic acids, peptides and proteins

  • Pharmaceuticals and veterinary preparations, in particular for treating cancerous diseases, infections, autoimmune disorders and metabolic disorders; diagnostic products, namely diagnostic preparations and materials

  • Treatment and conversion of material, namely custom manufacturing of chemical and biochemical preparations; custom manufacturing of biopharmaceuticals, chemical agents for laboratory use, in particular nucleic acids, peptides and proteins, pharmaceutical products of all kinds, in particular for treating cancerous diseases, infections and autoimmune disorders, and of chemical agents for the production of anticancer drugs and vaccines, in particular nucleic acids, peptides and proteins; custom manufacturing of therapeutic products, namely medical and veterinary preparations

  • Scientific research for medical and veterinary purposes, in particular for developing treatment concepts for cancerous diseases, infections, autoimmune diseases and metabolic disorders

  • Medical and veterinary services in connection with the treatment of cancerous diseases, infections and autoimmune disorders and metabolic disorders

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/030 Section B.1
  2. Bulletin 2025/209 Section A.1
FAQ

About RIBOLYSINS

Who owns the trademark "RIBOLYSINS"?

The EUIPO trademark "RIBOLYSINS" (application 019252243) is owned by BioNTech SE.

What is the status of "RIBOLYSINS"?

Its status at the EUIPO is: registered.

When was "RIBOLYSINS" registered?

It was registered on February 13, 2026 and is due to expire on September 25, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RIBOLYSINS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d4888-512c-72f8-8c70-780dad72adf5
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d4888-512c-72f8-8c70-780dad72adf5",
  "object": "trademark",
  "mark_text": "RIBOLYSINS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019252243",
  "filing_date": "2025-09-25",
  "nice_classes": [
    1,
    5,
    40,
    42,
    44
  ],
  "owners": [
    {
      "name": "BioNTech SE",
      "entity_id": "ent_019eb70b-b5ac-72d6-8ebd-9e89efdeedff"
    }
  ]
}